| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000042890 |
| Receipt No. | R000048956 |
| Scientific Title | Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region |
| Date of disclosure of the study information | 2021/01/04 |
| Last modified on | 2021/01/03 (Ver. 1) |
| Basic information | |||
| Public title | Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region | ||
| Acronym | AP-Colon SL study | ||
| Scientific Title | Multicenter prospective study of colorectal serrated lesions in the Asia-Pacific region | ||
| Scientific Title:Acronym | AP-Colon SL study | ||
| Region |
|
||
| Condition | ||
| Condition | Colorectal serrated lesion | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | The prevalence, risk factors, clinical significance, and many other aspects of colorectal serrated lesions are not sufficiently understood. The main objective of this study is to examine the risk factors and clinical significance (relationships to simultaneous colorectal cancer and other colorectal lesions) of colorectal serrated lesions after clarifying the prevalence of colorectal serrated lesions, with particular focus on sessile serrated lesions (SSL) by conducting a prospective survey of individuals undergoing colorectal cancer screening at multiple centers in the Asia-Pacific region. |
| Basic objectives2 | Others |
| Basic objectives -Others | This study also aims to examine their clinicopathological features, the ability of endoscopy to detect and diagnose these lesions, and the usefulness of such a risk-stratification score as the Asia Pacific Colorectal Screening (APCS) score. |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Colorectal SSL (sessile serrated lesion) |
| Key secondary outcomes | Non-SSL colorectal lesions (including non-SSL colorectal serrated lesions, colorectal cancer, advanced colorectal neoplasia, and colorectal adenoma), Serrated polyposis syndrome |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Diagnosis | |
| Type of intervention |
|
|
| Interventions/Control_1 | Observation of the entire proximal colon using chromoendoscopy (indigo carmine) during total colonoscopy. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | The study participants will be average-risk individuals (age: 40-74 years) undergoing total colonoscopy (TCS) for colorectal cancer screening for the first time in their lives at the participating institutions, who will receive a full oral explanation of the study using written materials, and who will provide consent in writing. Both individuals undergoing their first TCS for screening purposes and those undergoing first TCS following a positive fecal occult blood test in colorectal cancer screening are included in this study. | |||
| Key exclusion criteria | 1) Presence of uncontrollable complications, including unstable angina, acute myocardial infarction, heart failure, chronic respiratory disease, bleeding tendency, that make it difficult to safely perform TCS.
2) Clinical symptoms that indicate colorectal cancer, such as hematochezia or abdominal pain. 3) History of treatment for colorectal cancer or colorectal tumor. 4) History of colorectal surgery in which colorectum was resected. (Surgery not involving resection of colorectum such as appendectomy for appendicitis is not included in exclusion criteria) 5) Being from a family with hereditary colorectal cancer. 6) Difficult to survey baseline factors using a questionnaire. 7) Does not provide written consent. 8) Otherwise determined to be unfit by an investigator. |
|||
| Target sample size | 1000 | |||
| Research contact person | |||||||
| Name of lead principal investigator |
|
||||||
| Organization | National Cancer Center Hospital | ||||||
| Division name | Cancer Screening Center/ Endoscopy Division | ||||||
| Zip code | 104-0045 | ||||||
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan | ||||||
| TEL | 03-3542-2511 | ||||||
| tamatsud@ncc.go.jp | |||||||
| Public contact | |||||||
| Name of contact person |
|
||||||
| Organization | National Cancer Center Hospital | ||||||
| Division name | Cancer Screening Center/ Endoscopy Division | ||||||
| Zip code | 104-0045 | ||||||
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan | ||||||
| TEL | 03-3542-2511 | ||||||
| Homepage URL | |||||||
| masekigu@ncc.go.jp | |||||||
| Sponsor | |
| Institute | National Cancer Center |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Asian Novel Bio-Imaging and Intervention Group, National Cancer Center |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| IRB Contact (For public release) | |
| Organization | the Ethics Committee for Clinical Research of the National Cancer Center, Tokyo, Japan |
| Address | 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan |
| Tel | 03-3542-2511 |
| irst@ml.res.ncc.go.jp | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| Result | |
| URL related to results and publications | |
| Number of participants that the trial has enrolled | |
| Results | |
| Results date posted | |
| Results Delayed | |
| Results Delay Reason | |
| Date of the first journal publication of results | |
| Baseline Characteristics | |
| Participant flow | |
| Adverse events | |
| Outcome measures | |
| Plan to share IPD | |
| IPD sharing Plan description | |
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Date of IRB |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Other | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000048956 |